Add BrightSurf on Google Email

Study is first demonstration of noninvasive gene transcription measurement

Researchers at Rice University have developed a noninvasive method to track the expression of specific genes in living brain tissue, enabling real-time monitoring of gene activity. The tool, called In-vivo Tracking of Active Transcription (INTACT), uses engineered reporter molecules and sensors to detect target mRNA in the bloodstream.

SourceRice University·JournalNature Communications·TypeExperimental study·DateJun 1, 2026

Study identifies key genetic alterations and biomarker for blastic plasmacytoid dendritic cell neoplasm

A recent study discovered that the mutational landscape of blastic plasmacytoid dendritic cell neoplasm (BPDCN) is similar to other myeloid neoplasms. The researchers identified CCDC50 as a potential biomarker for this disease, which showed promising results in tracking disease activity and monitoring treatment success.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateJul 7, 2025

Relationship between mutation profile detected by next-generation sequencing and histopathological parameters in lung squamous cell carcinoma

The study evaluated the mutation profiles of lung squamous cell carcinoma (LSCC) detected by next-generation sequencing to assess relationships with clinicopathological parameters. Detection of mutations revealed associations between certain genes, such as PIK3CA and NF1, with specific histopathological features.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Pathology·DateMay 26, 2025

A new technique to use generative AI to design RNA

A new generative AI technique allows for the design of RNA molecules with improved functions, opening up potential for novel therapeutics and diagnostics. The SANDSTORM and GARDN systems enable the prediction and generation of RNA sequences tailored for specific tasks in cells or diagnostic assays.

SourceBoston University·JournalNature·TypeComputational simulation/modeling·DateMay 14, 2025

Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas using NGS and machine learning

A study published in Oncotarget has identified specific mutational and therapeutic landscapes of pancreatic cancer in the Russian population. By applying machine learning models to full exome individual data, researchers received personalized recommendations for targeted treatment options for each clinical case.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateFeb 14, 2024

Advanced viral diagnostics tool closer to widespread use

VirCapSeq-VERT, a next-generation sequencing-based screening and surveillance system, can detect any virus that can potentially infect humans with greater sensitivity and speed than other NGS platforms. The technology achieved clinical sensitivity of 99 percent and 100 percent clinical specificity in a validation study.

SourceColumbia University's Mailman School of Public Health·JournalJournal of Clinical Microbiology·TypeExperimental study·DateDec 20, 2023

De-code of the crop

A research group at Kyoto University has successfully developed a self-fertile buckwheat variety and a new type of the crop with a sticky texture. This breakthrough could contribute to the efficient breeding of less-common orphan crops, addressing the world's growing food demands.

SourceKyoto University·JournalNature Plants·TypeExperimental study·DateAug 11, 2023

AMP offers evidence-based recommendations for next-generation sequencing germline variant confirmation

The Association for Molecular Pathology (AMP) has published a report establishing evidence-based recommendations for orthogonal confirmation practices of germline variants detected by next-generation sequencing. The guidelines aim to promote standardization, transparency, and quality improvement among laboratories.

SourceAssociation for Molecular Pathology·JournalJournal of Molecular Diagnostics·DateMay 18, 2023

Automated, accurate reporting for NGS-based clonality testing

Researchers have developed an automated calling algorithm for determining B and T cell clonality from NGS data with greater sensitivity than previous models. The new model increases the assay's sensitivity in detecting clonality, allowing for more accurate diagnosis and monitoring of lymphoproliferative disorders.

SourceImpact Journals LLC·JournalOncotarget·TypeData/statistical analysis·DateMay 16, 2023

Performance of OncoK9® in real-world veterinary practice mirrors clinical validation study

A new study from PetDx shows OncoK9 performs similarly to its landmark clinical validation study in real-world settings, detecting 26 types of cancer in high-risk dogs. The test also provides peace of mind for veterinarians and families by detecting cancer in over 94% of negative cases.

SourceStephens & Associates·JournalJournal of the American Veterinary Medical Association·TypeRandomized controlled/clinical trial·DateMar 22, 2023

Oncotarget | Treasures from trash in cancer research

A new study explores the value of 'trash data' from cancer genome sequencing, identifying new strategies to uncover previously unexplored information. The researchers found that genomic and transcriptomic data contain relevant information that can help elucidate carcinogenesis and discover putative biomarkers with clinical applications.

SourceImpact Journals LLC·JournalOncotarget·TypeData/statistical analysis·DateNov 23, 2022

Oncotarget | Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas

A new study analyzed tumor biopsies from patients with newly-diagnosed germinal center B cell lymphoma and found that CREBBP mutations were associated with lower disease-free survival rates. The researchers identified CLMA as a practical tool to translate experimental findings into clinical applications.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateNov 17, 2022

Association for molecular pathology offers recommendations for in silico approaches for validating next-generation sequencing analysis pipelines

The Association for Molecular Pathology (AMP) has published consensus recommendations for using in silico approaches to validate Next-Generation Sequencing (NGS) data analysis pipelines. The guidelines provide expert opinion on the advantages and disadvantages of different types of in silico data and offer general recommendations for s...

SourceAssociation for Molecular Pathology·JournalJournal of Molecular Diagnostics·DateOct 18, 2022

Chromosome-scale genome of a gentle giant

Researchers have completed and released a chromosome-scale genome sequence of the Aldabra giant tortoise, providing a much-needed genetic resource for rescue efforts. The data will aid in breeding efforts, comparative studies with other tortoise species, and understanding the species' remarkable size.

SourceGigaScience·JournalGigaScience·TypeExperimental study·DateOct 11, 2022

A blueprint for life forms on Mars?

Researchers at McGill University have discovered microbes that can survive in conditions similar to those on Mars. These microorganisms thrive in extremely salty, cold, and oxygen-free environments by eating and breathing simple inorganic compounds. The study provides insights into the possibility of life on Mars.

SourceMcGill University·JournalThe ISME Journal·DateJun 21, 2022

Genetic test can diagnose certain immune system disorders

Researchers developed a genetic test that diagnoses primary immunodeficiency disorders (PID), revealing inherited genetic defects in nearly half of patients. The test uses next-generation sequencing technology to identify specific gene variants associated with PID, enabling targeted treatment and earlier intervention for family members.

SourceElsevier·JournalJournal of Molecular Diagnostics·TypeExperimental study·DateMay 23, 2022

Integrative approach by NUS biologists increases accuracy of mosquito vector surveillance

A team of researchers from NUS developed an integrative approach to boost accuracy in mosquito surveillance by including larvae and species identification using mini-barcodes. This approach improves overall diversity estimates by 38% compared to adult-only data, contributing to baseline knowledge on potential vectors in Singapore.

SourceNational University of Singapore·JournalJournal of Applied Ecology·DateAug 20, 2021

New versatile genetic test for lymphoid neoplasms supports personalized management of patients and further research

Researchers have developed a new integrative genetic test, LYNX, that analyzes standard and novel molecular markers in common lymphoid neoplasms. The test provides accurate detection of mutations, identification of large genome-wide chromosomal aberrations, and assessment of immunoglobulin and T-cell receptor gene rearrangements.

SourceElsevier·JournalJournal of Molecular Diagnostics·TypeExperimental study·DateJul 29, 2021